MedNation AG

DB:EIF Stock Report

Market Cap: €4.5m

MedNation Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for MedNation.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth26.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Investors Will Want MedNation's (FRA:EIF) Growth In ROCE To Persist

Nov 19
Investors Will Want MedNation's (FRA:EIF) Growth In ROCE To Persist

MedNation's (FRA:EIF) Earnings Are Weaker Than They Seem

Oct 07
MedNation's (FRA:EIF) Earnings Are Weaker Than They Seem

Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost

Oct 03
Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost

Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost

Oct 03
Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost

The Return Trends At MedNation (FRA:EIF) Look Promising

Mar 06
The Return Trends At MedNation (FRA:EIF) Look Promising

Investors Still Aren't Entirely Convinced By MedNation AG's (FRA:EIF) Revenues Despite 31% Price Jump

Jan 03
Investors Still Aren't Entirely Convinced By MedNation AG's (FRA:EIF) Revenues Despite 31% Price Jump

These 4 Measures Indicate That MedNation (FRA:EIF) Is Using Debt Extensively

Dec 23
These 4 Measures Indicate That MedNation (FRA:EIF) Is Using Debt Extensively

MedNation (FRA:EIF) Is Looking To Continue Growing Its Returns On Capital

Oct 10
MedNation (FRA:EIF) Is Looking To Continue Growing Its Returns On Capital

MedNation AG's (FRA:EIF) 32% Dip In Price Shows Sentiment Is Matching Earnings

Jul 29
MedNation AG's (FRA:EIF) 32% Dip In Price Shows Sentiment Is Matching Earnings

Returns On Capital Are Showing Encouraging Signs At MedNation (FRA:EIF)

Jun 29
Returns On Capital Are Showing Encouraging Signs At MedNation (FRA:EIF)

Returns Are Gaining Momentum At Eifelhöhen-Klinik (FRA:EIF)

Dec 03
Returns Are Gaining Momentum At Eifelhöhen-Klinik (FRA:EIF)

These 4 Measures Indicate That Eifelhöhen-Klinik (FRA:EIF) Is Using Debt Extensively

Oct 09
These 4 Measures Indicate That Eifelhöhen-Klinik (FRA:EIF) Is Using Debt Extensively

Is Eifelhöhen-Klinik (FRA:EIF) Using Debt Sensibly?

Jun 03
Is Eifelhöhen-Klinik (FRA:EIF) Using Debt Sensibly?

Is Eifelhöhen-Klinik (FRA:EIF) Using Debt In A Risky Way?

Oct 16
Is Eifelhöhen-Klinik (FRA:EIF) Using Debt In A Risky Way?

Is Eifelhöhen-Klinik (FRA:EIF) Using Too Much Debt?

Jun 07
Is Eifelhöhen-Klinik (FRA:EIF) Using Too Much Debt?

Will Eifelhöhen-Klinik's (FRA:EIF) Growth In ROCE Persist?

Feb 22
Will Eifelhöhen-Klinik's (FRA:EIF) Growth In ROCE Persist?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MedNation has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

DB:EIF - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202447334N/A
3/31/202446333N/A
12/31/202345223N/A
9/30/202343012N/A
6/30/202341-201N/A
3/31/202340-201N/A
12/31/202239-201N/A
9/30/202239-322N/A
6/30/202239-334N/A
3/31/202238-434N/A
12/31/202137-434N/A
9/30/202136-323N/A
6/30/202135-222N/A
3/31/202136-233N/A
12/31/202036-145N/A
9/30/202039-234N/A
6/30/202042-223N/A
3/31/202046-123N/A
12/31/201950-123N/A
9/30/201950-123N/A
6/30/201951-133N/A
3/31/201951-112N/A
12/31/201851-100N/A
9/30/201850-1-11N/A
6/30/2018490-12N/A
3/31/2018490N/A2N/A
12/31/2017480N/A2N/A
9/30/2017480N/A1N/A
6/30/201748-1N/A1N/A
3/31/2017492N/A1N/A
12/31/2016495N/A1N/A
9/30/2016495N/A2N/A
6/30/2016495N/A3N/A
3/31/2016482N/A2N/A
12/31/201547-1N/A1N/A
9/30/201546-1N/A2N/A
6/30/201544-1N/A2N/A
3/31/201544-1N/A3N/A
12/31/2014430N/A4N/A
9/30/2014420N/A5N/A
6/30/2014421N/A5N/A
3/31/2014410N/A4N/A
12/31/2013400N/A3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if EIF's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if EIF's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if EIF's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if EIF's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if EIF's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if EIF's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 10:06
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MedNation AG is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hartmut SchmidtHPS Research